Skip to main content

Table 3 Efficacy of artesunate-amodiaquine or artemether-lumefantrine in ≥2 years old malarious children according to study site and year of enrolment

From: Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under

Site (Year) PCR uncorrected PCR corrected
ACPR_u Failure_u Total ACPR_c Recrudescence Total % Recrudescence
Artesunate-amodiaquine
 Ibadan (2005–2010) 15 0 15 15 0 15 -
 Damboa (2009–2010) 17 0 17 17 0 17 -
 Agbani (2009–2010) 23 5 28 23 4 27 14.8
 Makarfi (2009–2010) 17 0 17 17 0 17 -
 Ijede (2009–2010) 14 0 14 14 0 14 -
 Barkin Ladi (2009–2010) 15 3 18 15 0 15 -
 Ibadan (2011–2015) 11 0 11 11 0 11 -
 Total (2005–2015) 112 8 120 112 4 116 3.4
Artemether-lumefantrine
 Ibadan (2005–2010) 32 0 32 32 0 32 -
 Damboa (2009–2010) 7 0 7 7 0 7 -
 Agbani (2009–2010) 27 2 29 27 2 29 6.9
 Makarfi (2009–2010) 23 1 24 23 0 23 -
 Ijede (2009–2010) 13 1 14 13 0 13 -
 Barkin Ladi (2009–2010) 17 4 21 17 3 20 15
 Ibadan (2011–2015) 3 0 3 3 0 3 -
 Total (2005–2015) 122 8 130 122 5 127 3.9
  1. PCR polymerase chain reaction, ACPR_u adequate clinical and parasitological response uncorrected, ACPR_c adequate clinical and parasitological response corrected, Failure_u treatment failure uncorrected